ALPN
Alpine Immune Sciences, Inc. Common Stock
ALPN
ALPN
Delisted
ALPN was delisted on the 17th of May, 2024.
44 hedge funds and large institutions have $160M invested in Alpine Immune Sciences, Inc. Common Stock in 2020 Q4 according to their latest regulatory filings, with 11 funds opening new positions, 13 increasing their positions, 8 reducing their positions, and 2 closing their positions.
Holders
44
Holders Change
+9
Holders Change %
+25.71%
% of All Funds
0.78%
Holding in Top 10
–
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-100%
% of All Funds
–
New
11
Increased
13
Reduced
8
Closed
2
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
1 |
APM
1
Avidity Partners Management
Dallas,
Texas
|
$15.7M |
2 |
2
Morgan Stanley
New York
|
$4.76M |
3 |
3
Vanguard Group
Malvern,
Pennsylvania
|
$6.9M |
4 |
CCM
4
CAAS Capital Management
New York
|
$1.87M |
5 |
PVI
5
Pura Vida Investments
New York
|
$1.73M |